Pharma Mar, S.A.
General ticker "PHMMF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6B (TTM average)
Pharma Mar, S.A. follows the US Stock Market performance with the rate: 5.0%.
Estimated limits based on current volatility of -0.0%: low 86.28$, high 86.28$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-06-26, amount 0.93$ (Y1.08%)
Short-term PHMMF quotes
Long-term PHMMF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €196.34MM | €158.15MM | €174.85MM |
| Operating Expenses | €152.27MM | €161.98MM | €168.39MM |
| Operating Income | €44.07MM | €-3.83MM | €6.47MM |
| Non-Operating Income | €-0.28MM | €0.20MM | €5.52MM |
| Interest Expense | €2.38MM | €2.42MM | €2.47MM |
| R&D Expense | €83.45MM | €99.30MM | €103.50MM |
| Income(Loss) | €43.79MM | €-3.62MM | €11.98MM |
| Taxes | €0.00MM | €-4.76MM | €0.00MM |
| Profit(Loss)* | €49.36MM | €1.14MM | €26.12MM |
| Stockholders Equity | €222.96MM | €193.44MM | €208.36MM |
| Inventory | €27.75MM | €39.29MM | €50.89MM |
| Assets | €393.26MM | €340.52MM | €349.64MM |
| Operating Cash Flow | €38.32MM | €-13.45MM | €6.03MM |
| Capital expenditure | €8.85MM | €15.96MM | €15.51MM |
| Investing Cash Flow | €10.88MM | €-43.05MM | €1.03MM |
| Financing Cash Flow | €-13.37MM | €-32.14MM | €-5.35MM |
| Earnings Per Share** | €2.73 | €0.06 | €1.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.